- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03241862
Assess the Impact of Lip Rejuvenation on Projected First Impressions and Mood Perceptions
Assess the Impact of Lip Rejuvenation With Restylane® Silk on Projected First Impressions and Mood Perceptions
20 subjects with mild to severe oral commissures or none to severe perioral lines will be enrolled and injected with Restylane® Silk. Photographs will be taken prior to and 14 days after Optimal Cosmetic Results has been achieved, as judged by the investigator.
Changes in the projected first impression will be assessed by a total of 200 blinded evaluators rating the photographs of subjects from the baseline and from 14 days post achieving the Optimal Cosmetic Results. Changes in subjects' mood will be self-assessed through Subjective Happiness Scale and Happiness Measures questionnaires. Aesthetic alterations will be assessed by the investigator via the Global Aesthetic Improvement Scale, Oral Commissure Severity Scale, and the Perioral Lines Severity Scale as well as by the self-assessment of subjects using the Global Aesthetic Improvement Scale.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- DeNova Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject is an adult of at least 21 years of age;
- Subject has mild to severe oral commissures or none to severe perioral lines, as assessed by the treating investigator;
- Subject is willing and able to provide written informed consent prior to the performance of any study related procedure;
- Subject is willing and able to comply with the protocol requirements; and
- Subject is willing and able to provide written photo consent and adhere to the photography and video procedures such as removal of jewelry and makeup
Exclusion Criteria:
- Subjects who have received lip filler treatments in the past 12 months or neurotoxin injections in the past 6 months;
- Subjects who plan to undergo neurotoxin treatments, ablative skin treatments, facial cosmetic surgery, or other injectable filler treatments during the course of the study;
- Subjects with a known allergy or sensitivity to any component of the study ingredients;
- Subjects with a history of bleeding disorders;
- Female subjects who are pregnant or nursing as well as those who are of childbearing potential but do not employ adequate birth control methods;
- Subjects with severe allergies manifested by a history of anaphylaxis or presence of multiple severe allergies;
- Subjects with previous history of sensitivity to amide type local anesthetics;
- Current history of chronic drug or alcohol abuse;
- Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study product;
- Subjects who, in the investigator's opinion, have a history of poor cooperation, non-compliance with medical treatment, or unreliability; and
- Enrollment in any active study involving the use of investigational devices or drugs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Restylane® Silk
All subjects enrolled in the study will undergo lip rejuvenation treatment with Restylane® Silk.
|
Restylane® Silk (Galderma Laboratories, L.P.) is a hyaluronic acid injectable filler, which is approved by the FDA for submucosal implantation for lip augmentation and dermal implantation for correction of perioral rhytids.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
First Impressions
Time Frame: 1 month
|
The projected first impressions are assessed by blinded evaluators using photographs. The projected first impressions are assessed by blinded evaluators using the First Impression Questionnaire (FIQ). Each of the below First Impression Questionnaire (FIQ) categories is scored between 1 (disagree)-10 (agree) and a total of 8 categories (see below) are assessed for a total possible score of 80. All scores will be graded out of a total possible score of 80 points Social skills Academic Performance Dating Success Occupational success Attractiveness Financial Success Relationship success Athletic success Total scores closer to 80 indicate a more favorable outcome. |
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appearance of the Lip and Perioral Area
Time Frame: Visit 1 at Baseline and Visit 3 (Week 4) or Visit 4 (Week 6)
|
Changes in the appearance of the lip and the perioral area are assessed by the PI using the Oral Commissure Severity Scale (OCSS) at Visit 1 and Visit 3/4 Oral Commissure Severity Scale (OCSS): graded from None (0), Mild (1), Moderate (2), Severe (3) None: No wrinkle or fold; slight upturned commissures Mild: Shallow, just perceptible wrinkle or crease; horizontal or slightly downturned corners Moderate: Moderately deep and/or long wrinkle or crease; downturned corners Severe: Very deep and/or long wrinkle or crease; frown at rest |
Visit 1 at Baseline and Visit 3 (Week 4) or Visit 4 (Week 6)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Silk-FI-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lip Rejuvenation
-
DeNova ResearchCompletedPerioral Rejuvenation | Upper Lip ProjectionUnited States
-
University of California, IrvineEnrolling by invitation
-
COR clinic of Regenerative MedicineCompleted
-
Erevna Innovations Inc.Completed
-
Musculoskeletal Transplant FoundationCompleted
-
Goldman, Butterwick, Fitzpatrick and GroffAcclaro CorporationNot yet recruitingFace Rejuvenation | Neck Rejuvenation
-
Syneron MedicalCompletedEvaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's AppearanceLaser Therapy | Rejuvenation
-
Alexandria UniversityCompletedLipofilling | Skin RejuvenationEgypt
-
Chulalongkorn UniversityVenus ConceptUnknownSkin Tightening and RejuvenationThailand
Clinical Trials on Restylane® Silk
-
Goldman, Butterwick, Fitzpatrick and GroffUnknown
-
Goldman, Butterwick, Fitzpatrick and GroffUnknown
-
Nashville Centre for Laser and Facial SurgeryCompletedTear Trough Deformity
-
Amanda D. Spear, CCRCCompleted
-
Skin Laser & Surgery SpecialistsCompletedPhotoaged Thinning of the Hands
-
University of PennsylvaniaGalderma R&DActive, not recruiting
-
Schweiger Dermatology, PLLCTerminated
-
Prollenium Medical Technologies Inc.Symbio, LLCCompleted
-
Galderma R&DCompleted